Skip to main content
. 2021 Mar 1:deab026. doi: 10.1093/humrep/deab026

Table I.

Comparison of clinical, social, and uro-andrological characteristics of the study sample (N = 43) stratified by clinical management of COVID-19.

Nonhospitalized (N = 12; 27.9%) Hospitalized (without ICU) (N = 26; 60.5%) ICU (N = 5; 11.6%) P valuea
DEMOGRAPHICS

Age (years) (median, IQR) 44 (33–49) 52 (48–58) 59 (56–59) 0.003
BMI (kg/m2) (median, IQR) 26.1 (23.7–27.9) 26.9 (23.6–31.0) 27.4 (26.3–28.7) 0.380
Smoking status Never (n, %) 9 (75.0%) 22 (84.6%) 4 (80.0%) 0.850
Current (n, %) 2 (16.7%) 1 (3.8%) 0 (0.0%) 0.157
Former (n, %) 1 (8.3%) 3 (11.5%) 1 (20.0%) 0.401
Period between last negative oropharyngeal swab and sample collection (days) (median, IQR) 30 (23–39) 37 (26–49) 24 (23–32) 0.558

ANDROLOGICAL FEATURES

Previous orchitis/genital infection (n, %) 2 (16.7%) 3 (11.5%) 0 (0.0%) 0.814
Previous parotitis (n, %) 4 (33.3%) 3 (11.5%) 1 (20.0%) 0.209
Previous surgically treated varicocele (n, %) 2 (16.7%) 2 (7.7%) 0 (0.0%) 0.747
IIEF-5b (median, IQR) 25 (24–25) 24 (21–25) 22 (22–23) 0.389
MSHQc erection scale (1–4) (median, IQR) 19 (17–20) 19 (17–20) 19 (17–20) 0.487
MSHQc ejaculation scale (5–12) (median, IQR) 37 (33–38) 36 (35–38) 34 (32–39) 0.165
MSHQc satisfaction scale (13–18) (median, IQR) 25 (23–25) 26 (24–30) 28 (26–29) 0.433
MSHQc sexual activity (19) (median, IQR) 3 (2–4) 3 (2–4) 4 (3–5) 0.554
MSHQc sexual activity (20, 21) (median, IQR) 8 (6–8) 8 (7–8) 8 (8–8) 0.179
MSHQc sexual desire (22–25) (median, IQR) 16 (14–16) 16 (16–17) 17 (15–18) 0.353
a

Calculated using Chi Quadro or Fischer test for categorical variables or ANOVA test for continuous variables.

b

International Index of Erectile Function Questionnaire.

c

Male Sexual Health Questionnaire.

COVID-19: coronavirus disease 2019; IQR: interquartile range, ICU: intensive care unit.